CannapharmaRx Inc. (CPMD)
OTC PINK OTC PINK Primary 
CannapharmaRx to Complete Additional Shipment in November
CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at its Cremona, Alberta facility, where cannabis cultivation remains on track according to the company's annual plan. Following the resignation of CEO Dean Medwid in early September, the company has been able to maintain uninterrupted operations while fulfilling and delivering its orders.
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
CALGARY, AB / ACCESSWIRE / August 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received three purchase orders for cannabis, for a total of 600KG, from Cantek Holdings. These orders are related to a previously announced supply agreement, and we are happy to announce that the market has proven to be pleased with our quality craft growing methodologies.
Q1 2024 Financial Results
CannaPharmaRx Announces Q1 2024 Financial Results Showcasing Commencement of Revenue CALGARY, AB / ACCESSWIRE / June 28, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it filed its first quarter 2024 financial reports for the quarter ending March 31, 2024, on Tuesday, June 25, 2024. Q1 2024 Financial Highlights: Revenue of $25,839 versus $0 in the comparable period of 2023 due to the beginning of product sales.
CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
CannaPharmaRx to Host Investor Conference Call - Tuesday May 21st, 2024 This updates the previous Press Release that had an incorrect date includedCALGARY, AB / ACCESSWIRE / May 20, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Tuesday, May 21, 2024, at 1PM Eastern time to give an update on progress.Chief Executive Officer Dean Medwid will be leading the discussion on various topics including:Review of financials and achievementsProduct and harvesting updateUpdate on purchase orders, inventory and shipmentsDistributor and expansion updateForecasted RevenuesInterested parties can join the conference call by dialing in:When: Tuesday, 05/21/24 at 1:00 pm ESTPhone Number: 530-881-1212ID Pin: 615-253-385#Passcode:1674609For interested individuals unable to join the conference call a recording will be available upon request.Please visit www.cannapharmarx.com for additional information about our company and products.About CannapharmaRx, Inc.CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.Safe Harbor StatementCautionary Note Regarding Forward-Looking Information or StatementsThis press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.Contact Information:Brokers and AnalystsChesapeake Group(410) 825-3930SOURCE: CannaPharmaRx
CannaPharmaRx to Host Investor Conference Call
CALGARY, AB / ACCESSWIRE / May 20, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it will hold an investor conference call on Wednesday, May 21, 2024, at 1PM Eastern time to give an update on progress.Chief Executive Officer Dean Medwid will be leading the discussion on various topics including:Review of financials and achievementsProduct and harvesting updateUpdate on purchase orders, inventory and shipmentsDistributor and expansion updateForecasted RevenuesInterested parties can join the conference call by dialing in:When: Tuesday, 05/21/24 at 1:00 pm ESTPhone Number: 530-881-1212ID Pin: 615-253-385#Passcode: 1674609For interested individuals unable to join the conference call a recording will be available upon request.Please visit www.cannapharmarx.com for additional information about our company and products.About CannapharmaRx, Inc.CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.Safe Harbor StatementCautionary Note Regarding Forward-Looking Information or StatementsThis press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.Contact Information:Brokers and AnalystsChesapeake Group(410) 825-3930SOURCE: CannaPharmaRx
